Mylan’s Ethical Meltdown

It has been quite a month for Mylan beginning with its first ethical lapse when it raised the price of the EpiPen by $500 from its 2008 price.  Facing a tidal wave of criticism, Mylan, a week later, pivoted and announced the launch of a generic EpiPen at one-half the price of the branded product, but still three times the 2008 price. Mylan now finds itself alone in a hostile wilderness…